Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• SWISS-APERO: Similar 3-Year Ischemic Risk With Amulet vs. Watchman FLX
  While there was no significant difference in ischemic risk in patients with atrial fibrillation between the Amulet and Watchman FLX devices at three years following left atrial appendage closure (LAAC), according to findings from the SWISS-APERO trial published in JACC...
• ACCEL Lite: Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF
  In this interview, Drs. Matthew Martinez and Barry Borlaug discuss “Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF.”
• Editors' Corner | Bridging Innovation and Practice
  Digital health technologies (DHTs) – from remote patient monitoring and virtual care to AI-powered data analysis – hold significant promise for enhancing the prevention, diagnosis and treatment of cardiovascular disease.
• Cover Story | The Future of Digital Health in Cardiovascular Disease: Bridging Innovation and Clinical Practice
  Cardiovascular diseases, including cardiometabolic diseases and related conditions, are the leading causes of death and disability worldwide. Despite advances in pharmacological treatments, significant gaps remain in achieving optimal cardiometabolic health, with disparities and barriers to accessing care.
• Feature | The Overlooked Cardiac Implications of Alpha-Gal Syndrome
  Alpha-Gal Syndrome (AGS) is an underrecognized, tick-borne allergic condition with emerging relevance in cardiovascular medicine. Sensitization to galactose-α-1,3-galactose (alpha-gal), a mammalian-derived carbohydrate absent in humans and other primates, occurs following tick bites...